Board of Directors

  • King

    David P. King

    Executive Chairman of the Board
      Mr. King has served as Executive Chairman of the Board and Director since November 1, 2019. Prior to that he was Chairman, President, and Chief Executive Officer of the Company since May 6, 2009. Prior to that date he served as a Director, President and Chief Executive Officer of the Company since January 1, 2007. Mr. King served as Executive Vice President and Chief Operating Officer from December 2005 to January 2007, as Executive Vice President of S… More >>
    • Kerrii B. Anderson

      Kerrii B. Anderson

      Director
      Financial Expert
      Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson was Chief Executive Officer of Wendy’s International, Inc., a restaurant operating and franchising company, from April 2006 until September 2008, when the company was merged with Triarc. Ms. Anderson served as Executive Vice President and Chief Financial Officer of Wendy’s International from 2000 to 2006. Prior to this position, she was Chief Financial Officer, … More >>
    • Jean

      Jean-Luc Bélingard

      Director
      Jean-Luc Bélingard has served as a director of the Company since April 28, 1995. From 2011 to December 2017, Mr. Bélingard served as Chairman of bioMérieux, the worldwide leader of the IVD microbiology segment and a non-US public company since 2010. Mr. Bélingard continues to serve on the board of directors of bioMérieux and as Vice President of Institut Mérieux. Prior to serving as Chairman, Mr. Bélingard had served as Chief Executive Officer of bioMé… More >>
    • gary

      D. Gary Gilliland M.D., Ph.D.

      Director
      D. Gary Gilliland has served as a director of the Company since April 1, 2014. Since January 2, 2015, Dr. Gilliland has served as President and Director of the NCI designated Fred Hutchinson Cancer Research Center in Seattle, WA. Prior to that, he was the inaugural Vice Dean and Vice President for Precision Medicine at the University of Pennsylvania Perelman School of Medicine from October 2013 to January 2015, where he was responsible for synthesizing… More >>
    • kong

      Garheng Kong M.D., Ph.D.

      Director
      Dr. Garheng Kong has served as a director of the Company since December 1, 2013. Dr. Kong is the Managing Partner of HealthQuest Capital, a healthcare-focused investment firm, and was previously a general partner at Sofinnova Ventures, a position he held from 2010 to 2013. Before joining Sofinnova, Dr. Kong was a general partner from 2000 to 2010 at Intersouth Partners, a venture capital firm where he was a founding investor or board member for various… More >>
    • peter

      Peter M. Neupert

      Director
      Financial Expert
      Lead Director
      Peter M. Neupert has served as a director of the Company since January 2013. Mr. Neupert was an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, from January 2012 until June 2015. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Neupert served on the President’s Information Technology Advisory Committee (… More >>
    • Richelle  Parham

      Richelle P. Parham

      Director
      Richelle Parham has served as a director of the Company since February 8, 2016. In October 2019, Ms. Parham joined WestRiver Group, as a Managing Director, which is a collaboration of leading investment firms that provides integrated capital solutions to the global innovation economy with investments focused on technology, life sciences, energy and experiential sectors. She previously was a General Partner of Camden Partners, a private equity firm, fro… More >>
    • schechter

      Adam H. Schechter

      President and CEO
        Adam H. Schechter has served as President, Chief Executive Officer and Director of the Company since November 1, 2019. Prior to that he was a Director since April 1, 2013. Mr. Schechter was an Executive Vice President of Merck & Co., Inc. from 2010 to 2018, where he was a member of Merck’s executive committee and pharmaceutical and vaccines operating committee. Since January 2019, Mr. Schechter has served as special advisor to the CEO of Merck. He … More >>
      • williams

        R. Sanders Williams, M.D.

        Director
        Dr. R. Sanders Williams has served as a director of the Company since May 16, 2007. Dr. Williams has served as President Emeritus of The J. David Gladstone Institutes since January 1, 2018. Prior to this appointment, he was president of The J. David Gladstone Institutes since November 2009, and he served as Chief Executive Officer of The J. David Gladstone Foundation until December 31, 2018. Dr. Williams also currently is Professor of Medicine at the U… More >>